Kadmon preps filing for GVHD drug belumosudil after phase 3 winNew York biotech Kadmon is on course to file for FDA approval of belumosudil for chronic graft versus Share XKadmon preps filing for GVHD drug belumosudil after phase 3 winhttps://pharmaphorum.com/news/kadmon-preps-filing-for-gvhd-drug-belumosudil-after-phase-3-win/
